Guangdong Marubi Biotechnology Co (603983.SS) stock: key figures, P/E, revenue and dividend
Consumer Staples · Personal Care Products · China · ISIN CNE100003M51
Guangdong Marubi Biotechnology Co financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.97 bn CNY | 3.46 bn CNY |
| Gross profit | 2.18 bn CNY | 2.57 bn CNY |
| Operating income | 380.94 m CNY | 253.91 m CNY |
| EBIT | 339.19 m CNY | 299.01 m CNY |
| Net income | 341.63 m CNY | 247.24 m CNY |
| Diluted EPS – continuing operations | 0.85 CNY | 0.62 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands. The company was founded in 2002 and is based in Guangzhou, China.
More stocks
- GoTo Gojek Tokopedia PT (GOTO.JK)
- NP3 Fastigheter AB (NP3.ST)
- Beach Energy Ltd (BPT.AX)
- Esentia Energy Development SA (ESENTIAII.MX)
- SonoScape Medical Corp (300633.SZ)
- Lightspeed Commerce Inc (LSPD.TO)
- Vanchip (Tianjin) Technology Co. Ltd. A (688153.SS)
- Mezzion Pharma Co.Ltd (140410.KQ)
- Pacira BioSciences, Inc. (PCRX)
- Hongrun Construction Group Co Ltd (002062.SZ)
- PHIBRO ANIMAL HEALTH CORP (PAHC)
- Mayr-Melnhof Karton AG (MMK.VI)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.